Y Yarden

Weizmann Institute of Science — Israel

Medicine · Health Sciences

11h-index2.1kcitations17works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HER2/EGFR in Cancer Research(11), Monoclonal and Polyclonal Antibodies Research(7), Cancer-related Molecular Pathways(3), Glycosylation and Glycoproteins Research(3), Breast Cancer Treatment Studies(2)

Publications17 total

Present and future breast cancer management—bench to bedside and back: a positioning paper of academia, regulatory authorities and pharmaceutical industry
Annals of Oncology·2013· 7 cited
Endocytosis and Cancer
Cold Spring Harbor Perspectives in Biology·2013· 397 citedOpen Access
Deubiquitination of EGFR by Cezanne-1 contributes to cancer progression
Oncogene·2011· 103 citedOpen Access
White paper: The International Receptor Tyrosine Kinase Networks Consortium
2005
Differences in response of breast cancer molecular profiles of patients likely to respond to either tyrosine kinase inhibitors or to erbB targeted therapies
Journal of Clinical Oncology·2004· 2 cited
Molecular mechanisms underlying ErbB2/HER2 action in breast cancer
Oncogene·2000· 615 cited
Neuregulins and Their Receptors: A Versatile Signaling Module in Organogenesis and Oncogenesis
Neuron·1997· 472 citedOpen Access
Molecular and clinical aspects of the Neu/ErbB-2 receptor tyrosine kinase
Cancer treatment and research·1994· 28 cited
CONVERGENCE OF SIGNALING BY INTERLEUKIN-3, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR, AND MAST CELL GROWTH FACTOR ON JAK2 TYROSINE KINASE
Oncogene·1994· 2 cited
Neural expression and chromosomal mapping of Neu differentiation factor to 8p12-p21.
Proceedings of the National Academy of Sciences·1993· 116 cited
Signal transduction by the neu/ebrB-2 receptor: A potential target for anti-tumor therapy
The Journal of Steroid Biochemistry and Molecular Biology·1992· 24 cited
Interkinase domain of kit contains the binding site for phosphatidylinositol 3' kinase.
Proceedings of the National Academy of Sciences·1992· 133 citedOpen Access
Agonistic antibodies stimulate the kinase encoded by the neu protooncogene in living cells but the oncogenic mutant is constitutively active.
Proceedings of the National Academy of Sciences·1990· 104 citedOpen Access
Experimental approaches to hypothetical hormones: detection of a candidate ligand of the neu protooncogene.
Proceedings of the National Academy of Sciences·1989· 111 citedOpen Access
Structural and Functional Aspects of Signal Transduction by Receptor Tyrosine Kinases
1989
Protein Kinases in Cellular Signal Transduction: Tyrosine Kinase Growth Factor Receptors and Protein Kinase C
Cold Spring Harbor Symposia on Quantitative Biology·1986· 25 cited
Phosphoamino acid specificity of the EGF-receptor kinase system in normal mitogenically responsive human cells
Cell Biology International Reports·1983· 2 cited

Frequent Co-authors

Joseph Schlessinger(3), Ilana Stancovski(2), Michael Sela(2), Sarah Bacus(2), Daniel Harari(1), Steven J. Burden(1), Ira Mellman(1), Sima Lev(1), David Givol(1), Avi Orr‐Urtreger(1), Luba Trakhtenbrot(1), R Ben-Levy(1), D Wen(1), Gideon Rechavi(1), Peter Lonai(1), R A Weinberg(1), Fresia Pareja(1), Daniela A. Ferraro(1), Charles Rubin(1), Hadas Cohen‐Dvashi(1)